Lepu Medical Technology (Beijing) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000H44
CNY
15.66
-0.08 (-0.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,612.62
1,713.07
1,290.24
1,387.25
1,441.71
1,897.68
1,690.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,612.62
1,713.07
1,290.24
1,387.25
1,441.71
1,897.68
1,690.03
Raw Material Cost
670.19
715.19
712.18
677.11
643.80
708.84
760.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
43.84
44.73
52.80
41.03
44.96
42.21
46.14
Selling and Distribution Expenses
363.72
388.23
739.54
407.43
456.50
423.19
615.19
Other Expenses
12.25
13.34
13.73
13.75
9.19
13.33
14.26
Total Expenditure (Excl Depreciation)
1,200.29
1,281.53
1,641.86
1,263.07
1,237.16
1,307.51
1,564.31
Operating Profit (PBDIT) excl Other Income
412.29999999999995
431.5
-351.59999999999997
124.2
204.60000000000002
590.2
125.7
Other Income
2.58
59.78
-4.24
63.32
61.86
71.97
41.89
Operating Profit (PBDIT)
588.60
666.33
-393.05
355.06
408.12
821.60
196.25
Interest
43.84
44.73
52.80
41.03
44.96
42.21
46.14
Exceptional Items
-3.23
0.94
-51.36
-18.38
3.76
3.42
-34.38
Gross Profit (PBDT)
942.43
997.88
578.05
710.14
797.91
1,188.84
929.61
Depreciation
177.28
177.28
168.45
168.45
159.79
159.79
154.18
Profit Before Tax
364.24
445.25
-665.66
127.21
207.14
623.03
-38.44
Tax
42.09
87.69
-91.09
13.54
-8.43
114.45
92.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
312.39
378.54
-555.72
105.41
215.37
481.87
-95.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
312.39
378.54
-555.72
105.41
215.37
481.87
-95.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
9.77
-1.33
-30.34
-12.07
-18.12
10.89
-15.47
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
322.15
377.21
-586.05
93.34
197.25
492.76
-110.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
15,796.89
15,615.83
15,201.42
15,797.28
15,891.00
16,377.67
15,976.10
Earnings per share (EPS)
0.17
0.21
-0.3
0.06
0.12
0.26
-0.05
Diluted Earnings per share
0.17
0.21
-0.3
0.06
0.12
0.26
-0.05
Operating Profit Margin (Excl OI)
25.35%
25.06%
-43.19%
8.89%
12.93%
31.08%
0.01%
Gross Profit Margin
33.58%
36.34%
-38.54%
21.31%
25.45%
41.25%
6.85%
PAT Margin
19.37%
22.1%
-43.07%
7.6%
14.94%
25.39%
-5.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 11.85% vs -21.80% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 63.39% vs -48.06% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 69.22% vs -31.83% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -2.67% vs 3.45% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Lepu Medical Technology (Beijing) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,612.62
0
1,612.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,612.62
0
1,612.62
Raw Material Cost
670.19
0
670.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
43.84
0
43.84
Selling and Distribution Expenses
363.72
0
363.72
Other Expenses
12.25
0.00
12.25
Total Expenditure (Excl Depreciation)
1,200.29
0
1,200.29
Operating Profit (PBDIT) excl Other Income
412.33
0.00
412.33
Other Income
2.58
0
2.58
Operating Profit (PBDIT)
588.60
0
588.60
Interest
43.84
0
43.84
Exceptional Items
-3.23
0
-3.23
Gross Profit (PBDT)
942.43
0
942.43
Depreciation
177.28
0
177.28
Profit Before Tax
364.24
0
364.24
Tax
42.09
0
42.09
Provisions and contingencies
0
0
0.00
Profit After Tax
312.39
0
312.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
312.39
0
312.39
Share in Profit of Associates
0
0
0.00
Minority Interest
9.77
0
9.77
Other related items
0.00
0.00
0.00
Consolidated Net Profit
322.15
0
322.15
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
15,796.89
0
15,796.89
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
25.35%
0%
0.00
25.35%
Gross Profit Margin
33.58%
0%
0.00
33.58%
PAT Margin
19.37%
0%
0.00
19.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 161.26 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -5.87% vs 32.78% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.85% vs -21.80% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 32.22 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -14.58% vs 164.36% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 63.39% vs -48.06% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -3.38% vs 255.99% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 69.22% vs -31.83% in Jun 2024

Quarterly - Interest
Interest 4.38 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.01% vs -15.34% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -2.67% vs 3.45% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.35%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024